| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.34 | 4e-12 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.26 | 9e-08 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.79 | 0.002 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |